Literature DB >> 2787778

Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production.

H Taniguchi1, T Sakano, T Hamasaki, H Kashiwa, K Ueda.   

Abstract

Human adherent monocytes stimulated with 1 microgram/ml pertussis toxin (PT) produced interleukin-1 (IL-1), as measured by thymocyte co-stimulation assay and enzyme-linked immunosorbent assay (ELISA), specific for IL-1 alpha and IL-1 beta. To clarify the role of protein kinase C (PKC) and calmodulin in IL-1 production, we investigated the effects of a PKC inhibitor, H-7, and a calmodulin antagonist, W-7 on PT- and lipopolysaccharide (LPS)-induced IL-1 production by monocytes. Addition of 10 microM and 20 microM H-7 to the culture medium markedly suppressed both PT- and LPS-induced IL-1 production. PT-induced IL-1 production was significantly suppressed by 5 microM and 10 microM W-7. However, LPS-induced IL-1 production was not suppressed by W-7 at the concentrations tested. When monocytes were labelled with Quin 2/AM, IL-1 production by monocytes stimulated with PT and LPS was markedly suppressed. These results indicate that different pathways are involved in the IL-1 production by PT and LPS; both calmodulin- and PKC-dependent processes are necessary for the IL-1 production induced by PT, whereas LPS-induced IL-1 production is dependent on the PKC. Inhibition of IL-1 production by interfering with intracellular Ca2+ trafficking in Quin 2/AM-loaded monocytes may be associated with the inhibition of PKC and calmodulin activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787778      PMCID: PMC1385259     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  25 in total

1.  Biological properties of islets-activating protein (IAP) purified from the culture medium of Bordetella pertussis.

Authors:  M Yajima; K Hosoda; Y Kanbayashi; T Nakamura; I Takahashi; M Ui
Journal:  J Biochem       Date:  1978-01       Impact factor: 3.387

2.  The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.

Authors:  H Kashiwa; S Hyodo; T Kishi; T Karakawa; E Kittaka; T Suzawa; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

Review 3.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

Review 4.  Thin filament proteins and thin filament-linked regulation of vertebrate muscle contraction.

Authors:  P C Leavis; J Gergely
Journal:  CRC Crit Rev Biochem       Date:  1984

5.  Accumulation of lysophosphatidylinositol in RAW 264.7 macrophage tumor cells stimulated by lipid A precursors.

Authors:  R A Zoeller; P D Wightman; M S Anderson; C R Raetz
Journal:  J Biol Chem       Date:  1987-12-15       Impact factor: 5.157

6.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

7.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

8.  ADP-ribosylation of the specific membrane protein by islet-activating protein, pertussis toxin, associated with inhibition of a chemotactic peptide-induced arachidonate release in neutrophils. A possible role of the toxin substrate in Ca2+-mobilizing biosignaling.

Authors:  F Okajima; M Ui
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

9.  Islet-activating protein, pertussis toxin, inhibits Ca2+-induced and guanine nucleotide-dependent releases of histamine and arachidonic acid from rat mast cells.

Authors:  T Nakamura; M Ui
Journal:  FEBS Lett       Date:  1984-08-06       Impact factor: 4.124

10.  Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.

Authors:  T Tanaka; T Ohmura; T Yamakado; H Hidaka
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

View more
  6 in total

Review 1.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

2.  Effects of serine protease inhibitor, TAME, on IL-1 beta in LPS-stimulated human monocytes: relationship between synthesis and release of a 33-kDa precursor and the 17-kDa biologically active species.

Authors:  J J Jessop; S L Henry; T Hoffman
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

3.  Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors.

Authors:  R H See; A W Chow
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal.

Authors:  R Maldonado; O Valverde; C Garbay; B P Roques
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

5.  Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes.

Authors:  R G Coffey; L L Weakland; V A Alberts
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

6.  Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages.

Authors:  S L Weinstein; M R Gold; A L DeFranco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.